Christiane Naue

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series.

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series.

Journal: British journal of haematology

Published: July 05, 2025

Venous Thromboembolism Therapy with Edoxaban in Daily Care Patients: Results from the DRESDEN NOAC REGISTRY.

Venous Thromboembolism Therapy with Edoxaban in Daily Care Patients: Results from the DRESDEN NOAC REGISTRY.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: March 10, 2025

Patterns of atrial fibrillation anticoagulation with rivaroxaban - 7-year follow-up from the Dresden NOAC registry.

Patterns of atrial fibrillation anticoagulation with rivaroxaban - 7-year follow-up from the Dresden NOAC registry.

Journal: Thrombosis research

Published: December 29, 2023

Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRY.

Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRY.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: March 29, 2023

Clinical effectiveness and safety of edoxaban in obese patients - Results of the prospective Dresden NOAC Registry (NCT01588119).

Clinical effectiveness and safety of edoxaban in obese patients - Results of the prospective Dresden NOAC Registry (NCT01588119).

Journal: Thrombosis research

Published: January 23, 2023

Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY.

Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY.

Journal: Thrombosis research

Published: March 15, 2022

Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?

Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?

Journal: Hamostaseologie

Published: February 23, 2022

Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.

Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.

Journal: Research and practice in thrombosis and haemostasis

Published: August 06, 2021

Long-term VTE treatment with rivaroxaban: Results from the DRESDEN NOAC REGISTRY.

Long-term VTE treatment with rivaroxaban: Results from the DRESDEN NOAC REGISTRY.

Journal: Thrombosis research

Published: July 01, 2021

5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC Registry.

5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC Registry.

Journal: Thrombosis research

Published: November 11, 2020

Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry.

Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: April 23, 2020

Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRY.

Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRY.

Journal: Thrombosis research

Published: February 03, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026